The CLEC12A receptor marks human basophils: Potential implications for minimal residual disease detection in acute myeloid leukemia

ConclusionsIdentification and enumeration of basophils is of high relevance in diagnostic hematology and immunology. We here show that CLEC12A in a simple FCM assay consistently marks basophils. Importantly, as basophils are characterized by a CD45lowSSClow profile similar to the “blast‐gate” used for the evaluation of hematological disorders, awareness of minor normal CLEC12A+ subpopulations is crucial when using CLEC12A as a minimal residual disease marker in myeloid malignancies. © 2017 International Clinical Cytometry Society

Source: Cytometry Part B: Clinical Cytometry - August 11, 2017 Category: Molecular Biology Authors: Marie Toft ‐Petersen, Anne Stidsholt Roug, Trine Plesner, Lene Ebbesen, Gordon D. Brown, Line Nederby Tags: Original Article Source Type: research